Home › Aneurysms › Pennsylvania
Aneurysms clinical trials in Pennsylvania
7 studies for Aneurysms are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- The Trustees of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 to 79 · All sexes · Updated Sep 28, 2026 · NCT03536312The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
- University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07143019PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
- Lehigh Valley Hospital, Allentown
- University of Pennsylvania, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT04545502A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
- Hospital of the University of Pennsylvania, Philadelphia
- UPMC Presbyterian, Pittsburgh
Recruiting
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT07078383Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
Recruiting
Ages 18 to 75 · All sexes · Updated Mar 31, 2026 · NCT06693011Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
- Hospital of the University of Pennsylvania, Philadelphia
- Hospital of the University of Pennsylvania, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06218875Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- Hospital of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT02323581From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.